Daniel Grosslight

Stock Analyst at Citigroup

(0)
# 4073
Out of 5,291 analysts
130
Total ratings
30.61%
Success rate
-7.47%
Average return
27 Stocks
Name Action Price Target Current % Upside Ratings Updated
Hims & Hers Health
Reiterates: Sell
27 27
29.1 -7.22% 9 Mar 6, 2025
Cardinal Health
Maintains: Neutral
120 129
136.43 -5.45% 5 Jan 10, 2025
Evolent Health
Maintains: Buy
21 18
9.59 87.7% 4 Jan 10, 2025
GoodRx Holdings
Maintains: Buy
7 7
4.5 38.89% 7 Jan 10, 2025
Health Catalyst
Maintains: Buy
11 10
4.58 118.34% 8 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
713 677
668.25 1.31% 7 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 13
n/a n/a 9 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
31 35
26.02 34.51% 6 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
2 3
4.48 -49.78% 4 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
21 19
8.59 115.37% 5 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
22.57 10.77% 1 Apr 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
17 10
0.6 1466.67% 10 Apr 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
16
n/a n/a 2 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
21 19
8.12 133.99% 10 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
9 10
6.58 51.98% 7 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
7 8
9.35 -14.44% 7 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
185 195
n/a n/a 2 May 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 2
3.4 -63.24% 5 Apr 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
2
n/a n/a 1 Sep 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
14 18
n/a n/a 2 Jul 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
125 38
n/a n/a 1 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
7 4
2.64 32.58% 2 Nov 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
35 37
n/a n/a 4 Dec 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
125 170
n/a n/a 2 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
24 26
30.47 -14.67% 6 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
13
10.63 22.3% 1 Dec 11, 2019